It’s been months now since there has been a decline in serious COVID cases however, the effects are lingering and not getting resolved for many patients.
Continue readingUS Maternal Deaths Continues at a high rate
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
Maternal deaths are still high in the US and we know why
by Dr. Alan Kadish NMD
Maternal Rates of death
Lets take the issue of maternal death rates. You would think that after the thousands of years observing and having seen births that a safe childbirth would be a obvious outcome for most, and generally that’s the case. In the US the rate of maternal deaths is increasing.
The ” Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015” is a telling indictment of our health care system. The US is not making the expected progress of a so called first rate socioeconomic country. In fact were are ranked with some of the lowest 3rd word countries.

SOURCE The Global Burden of Disease 2015 Maternal Mortality study as published in The Lancet medical journal
Key issues
California, a different approach

Your state ?
Take Homes for all Women:
- If you live in Louisiana, Georgia, and Indiana, which have the highest rates of complications and death, consider options to a safer facility out of state.
- Ask if the hospital is following the California Maternal Quality Care Collaborative (CMQCC) recommendations and talk to some of the nursing staff to verify that indeed they have a hemorrhage cart in the delivery rooms.
- Inquire if the facility is participating with the COUNCIL ON PATIENT SAFETY IN WOMEN’S HEALTH CARE and implementing their “safety tools”
- Want to really get the inside scoop , ask for their maternity statistics and see how they rank, assuming your able to get them.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Chocolate everything your need to know
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
Who doesn’t like chocolate ?
by Dr. Alan Kadish
As the holiday season approaches I thought a quick overview of the state of chocolate would be in order. First the obvious there are two labeled chocolates, the real deal and milk chocolate, the fraud.
Real chocolates contain cacao butter and not milk substitutes. The difference is obvious both from a taste consideration and the legal labeling. Milk chocolate is simply the use of a limited amount of the cacao while substituting milk products. How much of a difference, well the United States government only requires a 10% concentration of chocolate liquor. In the European Union the regulations specify a minimum of 25% cocoa solids. However, an agreement was reached in 2000 that allowed an exception from these regulations in the UK, Ireland, and Malta, where “milk chocolate” can contain only 20% cocoa solids.
The dark chocolates with high cacao levels contain naturally occurring healthy components. The main focus is on the family of polyphenols, especially the flavanols. This group of natural chemicals has multiple positive impacts on our physiology, ie. it’s good for us.
Let’s also address two obvious issues, calories and sugar. Most of us do not need additional calories and do I need to even start the rant on sugar ? So when we consider ingesting chocolate we have some limits, no not the whole bar but rather in moderation. And remember the ingredients list should alway start with cacao, not sugar.
For our health the >70% rule should be considered. What’s the 70% rule ? When making a chocolate product you can choose to add or subtract the percentage of cacao into the final product. The rule of thumb, a higher percentage of cacao (cocoa) means a higher amount of flavanols. Most of the published studies highly suggest that at the 70% or greater level there are enough of the polyphenols to actually make a difference.
Now to confuse the issue a bit more when you process the cacao there are a couple of methods of changing the bitterness. One of the more popular methods is called dutch processing or processed with alkali. This changes the pH of the chocolate, modifying its color and give it a milder taste. Down side is that it also reduces the amount of flavanols present. There is a natural way of extracting the cacao butter called the broma process. Only some of the manufactures use this method, check the label.
Claims:
And you thought the label on food should be simple. Check out the potpourri of claims on chocolate labels. A host of which are ridiculous or just plain meaningless. How could a bar of chocolate be anything but gluten free, assuming it’s a chocolate bar without additives. But don’t stop at the other branding approaches. Think it’s all made by an artisan or perhaps is hand-crafted, some are however, does that claim matter ? And then we have the raw chocolate claims. The issue is the amount and temperature of processing. The down side is there is no universally agreed upon definition of what constitutes “raw”. Did you check the label for soy lecithin or milk products, as an emulsifier, in the ingredients list ? I generally find a different taste when these are added and prefer to keep the ingredients list to the minimum, with only the necessary components for great taste.
Allergens:
Allergens in the chocolate can happen if the manufacturing lines are in the same location as those using other ingredients such as milk, soy or nuts. Most labels will state something to the effect of having one of these allergens present and interestingly if your highly sensitive to milk you might be concerned as a Journal of Food Protection study done in 2017 that found 75% of dark chocolate bars tested contained a high enough level of milk allergens to be of concern.
Toxins:
Are there toxins in your chocolate ? There are, notably concerns are around the cadmium and lead from the ground that the cacao was grown in contaminated the chocolate. A study of 120 products highlighted some disturbing findings. The As You Sow organization, a consumer health protection organization posted their findings. The bottom line shop carefully and know your brand, it does make a difference. The organization used the Proposition 65 levels of lead and cadmium to determine safety. Absolutely appropriate especially for youngsters as there is no safe level of lead, period. The downside to their studies…not every brand has been tested and the results will vary dependent on the growing season, water issues and a host of other variables.
Published Studies:
How about we end with some good news ? There are a growing avalanche of studies showing positive impact from consumption of limited amounts of dark chocolate. From your brain health to your heart health and even your skin health, polyphenols can be a great natural way towards better health.
So enjoy some dark chocolate.
Take Home:
- Forget the fake, ie. milk chocolate….. go dark exclusively
- Consider Fair Trade products
- Get the 100% Organic, check the label
- > 70% cocoa content
- Preferentially purchase the products that are not processed with alkali
- Go GMO free
- Purchase the products with the least amount of lead and cadmium
- Remember the first ingredient should always be cacao
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Less births in the US for the second year
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_size=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”no” min_height=”” hover_type=”none” link=””][fusion_text]
Americans Are Having Fewer Babies. They Told Us Why.
Women have more options, for one. But a new poll also shows that financial insecurity is altering a generation’s choices.

Americans are having fewer babies. At first, researchers thought the declining fertility rate was because of the recession, but it kept falling even as the economy recovered. Now it has reached a record low for the second consecutive year.
Because the fertility rate subtly shapes many major issues of the day — including immigration, education, housing, the labor supply, the social safety net and support for working families — there’s a lot of concern about why today’s young adults aren’t having as many children. So we asked them.
Wanting more leisure time and personal freedom; not having a partner yet; not being able to afford child-care costs — these were the top reasons young adults gave for not wanting or not being sure they wanted children, according to a new survey conducted by Morning Consult for The New York Times.
About a quarter of the respondents who had children or planned to said they had fewer or expected to have fewer than they wanted. The largest shares said they delayed or stopped having children because of concerns about having enough time or money.
The survey, one of the most comprehensive explorations of the reasons that adults are having fewer children, tells a story that is partly about greater gender equality. Women have more agency over their lives, and many feel that motherhood has become more of a choice.
But it’s also a story of economic insecurity. Young people have record student debt, many graduated in a recession and many can’t afford homes — all as parenthood has become more expensive. Women in particular pay an earnings penalty for having children.
“We want to invest more in each child to give them the best opportunities to compete in an increasingly unequal environment,” said Philip Cohen, a sociologist at the University of Maryland who studies families and has written about fertility.
At the same time, he said, “There is no getting around the fact that the relationship between gender equality and fertility is very strong: There are no high-fertility countries that are gender equal.”
The United States seems to have almost caught up with most of the rest of the industrialized world’s low fertility rates. It used to have higher fertility for reasons like more teenage pregnancies, more unintended pregnancies and high fertility among Hispanic immigrants. But those trends have recently reversed, in part because of increased use of long-acting birth control methods like IUDs.
In the Morning Consult and Times survey, more than half of the 1,858 respondents — a nationally representative sample of men and women ages 20 to 45 — said they planned to have fewer children than their parents. About half were already parents. Of those who weren’t, 42 percent said they wanted children, 24 percent said they did not and 34 percent said they weren’t sure.
One of the biggest factors was personal: having no desire for children and wanting more leisure time, a pattern that has also shown up in social science research. A quarter of poll respondents who didn’t plan to have children said one reason was they didn’t think they’d be good parents.
Jessica Boer, 26, has a long list of things she’d rather spend time doing than raising children: being with her family and her fiancé; traveling; focusing on her job as a nurse; getting a master’s degree; playing with her cats.
“My parents got married right out of high school and had me and they were miserable,” said Ms. Boer, who lives in Portage, Mich. “But now we know we have a choice.”
She said she had such high expectations for parents that she wasn’t sure she could meet them: “I would have the responsibility to raise this person into a functional and productive citizen, and some days I’m not even responsible.”
This generation, unlike the ones that came before it, is as likely as not to earn less than their parents. Among people who did not plan to have children, 23 percent said it was because they were worried about the economy. A third said they couldn’t afford child care, 24 percent said they couldn’t afford a house and 13 percent cited student debt.
Financial concerns also led people to have fewer children than what they considered to be ideal: 64 percent said it was because child care was too expensive, 43 percent said they waited too long because of financial instability and about 40 percent said it was because of a lack of paid family leave.
Women face another economic obstacle: Their careers can stall when they become mothers.
This spring, Brittany Butler, 22, became the first person in her family to graduate from college, and she will start graduate school in social work in the fall. She said it would probably be at least 10 years before she considered having children, until she could raise them in very different circumstances than in her poor hometown neighborhood in Baton Rouge, La.
She admits being “a little nervous” that it may become harder to get pregnant, but she wants to pay off her student loans and, most of all, be able to live in a safe neighborhood.
“A lot of people, especially communities of color, can’t really afford that now,” she said. “I’m just apprehensive about going back to poverty. I know how it goes, I know the effects of it, and I’m thinking, ‘Can I ever break this curse?’ I would just like to change the narrative around.”
Starting a family used to be what people did to embark on adulthood; now many say they want to wait. Last year, the only age group in which the fertility rate increased was women ages 40 to 44. Delaying marriage and birth is a big reason people say they had fewer children than their ideal number: Female fertility begins significantly decreasing at age 32.
David Carlson, 29, graduated from college in 2010, when the job market was still rough. He and his wife had $100,000 in undergraduate debt between them. They both work full time — he in corporate finance and she in counseling — but they don’t yet feel they can take time away from their careers.
“Wages are not growing in proportion to the cost of living, and with student loans on top of that, it’s just really hard to get your financial footing — even if you’ve gone to college, work in a corporate job and have dual incomes,” said Mr. Carlson, who lives in Minneapolis and writes a personal finance blog for millennials.
He said they’d consider adoption if they decided to have children but had waited too long. Another option for having children later in life is egg freezing. Only 1 percent of female survey respondents said they had frozen their eggs — but almost half said they would if not for the cost.
Researchers say the United States could adopt policies that make it easier for people to both raise children and build careers. Government spending on child care for young children has the strongest effect. Policies that encourage parents to share child care help, too. Germany and Japan have used such ideas to reverse declining fertility.
High employment among women and high fertility don’t have to be in conflict, but they will be without such policies, said Olivier Thevenon, an economist studying child and family policies at the Organization for Economic Cooperation and Development.
“Whether the young generation will catch up later is not certain,” he said, “but will depend on their capacity to combine work and family.”
Claire Cain Miller writes about gender, families and the future of work for The Upshot. She joined The Times in 2008 and was part of a team that won a Pulitzer Prize in 2018 for public service for reporting on workplace sexual harassment issues.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
BRCA testing is now available through 23&Me
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
BRCA 1 & 2 genetic testing now more available
by Dr. Alan Kadish
You might remember when getting a BRCA test for the breast and ovarian cancer gene was a many thousands of dollar affair and only one company was the provider. Then in June 2013 the supreme court unanimously ruled that Myriad Genetics Inc’s , patent was invalidated. This lead to the overturning of all patents for the evaluation of naturally occurring genes.
Women who wanted to know if they are at risk for breast cancer can now find a test at a more reasonable price. Keep in mind that only 5-10% of breast cancers are directly related to BRCA mutations. Now for the new news, the FDA has approved 23&Me to do this testing with some considerations.
The story gets a bit murky about this point as you can’t just take some information from the test, extrapolate and be certain that you are or are not at risk. The exception is unless of course you are an Ashkenazi Jewish woman who has a family member with breast or ovarian cancer and the result is negative. This gal will sleep better at night knowing that risk is not in her code.
If you do a BRCA test, it’s important to know that there are many types of mutations in everyones genetic code. The key is to know which of the code problems could potentially become a health issue, such as a cancer. And it’s equally important to understand that even if you have what appears to be a high-risk mutation, it does not guarantee that you will develop any type of cancer. Not to make your job harder keep in mind that there are 5 types of mutations seen in doing genetic work.
They include:
- Deleterious mutation: The change is proven to cause significant risks.
- Suspected deleterious: While nothing is proven, the variation is currently believed to be harmful.
- Variant of uncertain significance (VUS): Whether the change has any effect is uncertain. This is a common test result, and most variations began in this category. As more evidence is acquired, these are re-classified.
- Variant, favor polymorphism: While nothing is proven, the variation is currently believed to be harmless.
- Benign polymorphism: The change is classified as harmless. These may be reported as “no mutation”.
Now for the rest of the story. Genetics is a fairly complex affair that is still very much in the infancy of both quality detection (reading the whole sequence) and understanding. In most cases science is still learning what really are the implications of most of the information. Many consumers assume improperly that the genetic tests are accurate to high precision levels and can be relied upon to give a clear path towards treatment or not.
Before you write off genetic testing keep in mind that overall the accuracy has been increasing logarithmically from the old style of devices only a few years ago to much more accurate outcomes and we are constantly learning of new combinations of both genes and their expressions. And if you do find a sequence that is indeed questionable you can have further evaluation done to verify if indeed it should/could be used to direct a therapy or change in your life style.
Take Aways:
I think the 23&Me testing can be very helpful, with proper interpretation
Other information from their testing can be useful and is relatively inexpensive
If you have ANY questions about the interpretation you should request a consult with a genetic counselor
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
| March 19, 2018
The biggest challenge, by far, will be to understand why and how the correct interpretation of DNA results can vary between people.
The FDA identified that this test presents a risk of an incorrect understanding of the test by consumers, false test results, and poor interpretation of the results. The agency requires that 23andMe puts “general and special controls” in place to reduce these risks. The company received a long list of warning statements, specifications, and limitations of the test that it needs to include in the labeling of the product and the pre-purchase information. The company is also required to conduct a user comprehension study to assure that consumers understand the material that is provided.
Whether the controls will help consumers to correctly understand and interpret the test and its results remains to be seen. The simple and uniform presentation of information that is needed to achieve that goal is at odds with the enormous variation in the quality, relevance, and value of scientific and clinical studies on which the test results are based. The biggest challenge, by far, will be to understand why and how the correct interpretation of DNA results can vary between people.
If you carry one of the three BRCA mutations, the interpretation is straightforward. It means that your breast cancer risk is much higher than that of other women. The significance of not carrying one of the three mutations depends on who you are.
If you are an Ashkenazi Jewish woman with a family history of breast cancer and your affected relatives carry one of the three mutations, then the absence of the mutation is an enormous relief.
If you are a non-Jewish woman, then the absence of these mutations means nothing, as you were unlikely to carry them at all. For you, getting screened is like taking a pregnancy test when you already know you are not pregnant.
And it also means nothing if you are a non-Jewish woman with a family history of breast cancer. The mutation that causes breast cancer in your family is likely one of the thousands of others that are known or one that is yet to be discovered.
The DNA test is equally accurate for all these women, but the value and effect of the test differ between them.
23andMe’s press release about the BRCA test does not mention “approval,” but correctly states that the company received FDA “authorization” to market the BRCA test. Also, in its advertising of the Genetic Health Risks and Carrier status tests, the two tests that the FDA allowed earlier, the company writes that each “meets FDA requirements.” But an authorized test that meets FDA requirements is not an FDA-approved test, and class II classification does not mean that the agency endorses direct-to-consumer genetic testing either. The FDA allows consumers to make their own decisions about genetic testing, including the bad ones. Time will tell whether those decisions are in consumers’ own best interests.
Cecile Janssens is a professor of Epidemiology at Emory University’s Rollins School of Public Health who studies the genetic prediction of disease.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Is your cell phone radiating your head and causing cancer ?
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
Controversies Cell Phones and Brain tumors, again
By Dr. Alan Kadish NMD
I know one can’t get too excited with another rerun of a rat study, however when was the last time you saw someone place a cell phone in her bra or a guy put the phone into their breast pocket ? Perhaps a little too close to the heart ? And can you be safe enough ?
For years now there has been the ongoing debates regarding the radiation from your cell phone and the question of “is it dangerous”. The jury is not quite in yet….but the alarmists are making waves. Theres more data to digest however, so let’s take a look at the new publications.
A quick overview of the latest study which is a re-review of the initially released information done in May of 2016, by the National Toxicology Program from the US Department of Health and Human Services, has shown “Clear Evidence” that there is a connection between radiation and heart tumors, in male rats and “some evidence” that it also caused tumors in their brains. For the female rats the results were less convincing, basically there were some heart tumors but not statistically significant, so we don’t know if it was the cell phone radiation or something else ?
In 2010 & 2011 two human studies were published. One was done based on an interviews with 2708 glioma and 2409 meningioma cases and matched controls, at 16 institutions in 13 countries and their findings; “..found that the heaviest mobile phone users were more likely to develop glioma—the same type of brain cancer the NTP (above) study found in the male rats. One of the senior toxicologist, who designed the studies concluded, “So there’s a concordance between the animal and human data,” . Not so fast….. The second study used a similar study design and found no association between acoustic neuromas, brain tumors, even with 10 years of use.
There is a glaring problem with this study design for both publications and they note as much. They asked people who had brain cancers about their exposures, after the fact, which is inherent in data error. People are terrible at recall when you ask specifics for long periods of time. Do you remember how many hours you used your phone last week and forget about last year ?
And not to confound the issue, they found only one style of brain tumors, not others, were associated with the radiation. So whats the real story ? We probably need a lot more data done in a controlled environment to really get the rest of the story. If your concerned with the radiation from your phone ….. have you checked the level of output at: Cell Phone Radiation ?
Take Aways:
Keep the phone as far away from your body as possible
Consider a wired head set vs putting the phone to your ear
Use the handsfree mode especially if your a heavy cell phone user
Get a low SAR rated phone
Avoid giving your phone to youngsters, due their developmental considerations
We now have the first clear evidence cell phone radiation can cause cancer in rats
This week, following three days of live-broadcast peer review sessions, experts concluded that a pair of federal studies show “clear evidence” that cell phone radiation caused heart cancer in male rats.
This substantially changes the debate on whether cell phone use is a cancer risk. Up until this point, the federal government and cell phone manufacturers operated on the assumption that cell phones cannot by their very nature cause cancer, because they emit non-ionizing radiation. Whereas ionizing radiation—the kind associated with x-rays, CT scans, and nuclear power plants, among others—definitely causes cancer at high enough doses, non-ionizing radiation was believed to not emit enough energy to break chemical bonds. That meant it couldn’t damage DNA, and therefore couldn’t lead to mutations that cause cancer.
But the pair of studies by the US National Toxicology Program found “clear evidence” that exposure to radiation caused heart tumors in male rats, and found “some evidence” that it caused tumors in the brains of male rats. (Both are positive results; the NTP uses the labels “clear evidence,” “some evidence,” “equivocal evidence” and “no evidence” when making conclusions.)
Tumors were found in the hearts of female rats, too, but they didn’t rise to the level of statistical significance and the results were labeled “equivocal;” in other words, the researchers couldn’t be sure the radiation is what caused the tumors.
The next scientific step will be to determine what this means for humans. The peer-reviewed papers will be passed on to the US Food and Drug Administration, which is responsible for determining human risk and issuing any guidelines to the public, and the Federal Communications Commission, which develops safety standards for cell phones. The FDA was part of the group of federal agencies who commissioned the studies back in the early 2000s.

Ronald Melnick, the NTP senior toxicologist who designed the studies (and who retired from the agency in 2009), says it’s unlikely any future study could conclude with certainty that there is no risk to humans from cell phone use. “I can’t see proof of a negative ever arising from future studies,” Melnick says.
He believes the FDA should put out guidance based on the results of the two rat studies. “I would think it would be irresponsible to not put out indications to the public,” Melnick says. “Maintain a distance from this advice from your children. Don’t sleep with your phone near your head. Use wired headsets. This would be something that the agencies could do right now.”
A RE-EVALUATION OF THE DATA
When the draft results of the papers were published earlier this year, all results were labeled “equivocal,” meaning the study authors felt the data weren’t clear enough to determine if the radiation caused the health effects or not. But the panel of peer reviewers (among them brain and heart pathologists, toxicologists, biostaticians, and engineers) re-evaluated the data and upgraded several of the conclusions to “some evidence” and “clear evidence.”

Peer review is a vital part of any scientific study; it brings several more lifetimes of expertise into the room to rigorously check a study for any weak points. Melnick calls the peer reviewers’ choice to change some conclusions an unusual move; “It’s quite uncommon that the peer review panel changes the final determination,” he says, noting if anything, he’s seen peer reviewers downgrade findings, not upgrade them. “Typically when NTP presents their findings, the peer review almost in all cases goes along with that.” In this case, the peer reviewers felt the data—when combined with their knowledge of the cancers and with the study design itself—was significant enough to upgrade several of the findings.
The peer reviewers did have some quibbles with the study; some wished it could have lasted longer (the rodents were exposed to radiation for two years) to catch later-developing tumors, for example, but others on the panel noted that the longer a rodent lives, the more likely it is to develop tumors regardless of radiation, making it harder to find the signal in the noise. Others wanted the researchers to have dissected the rodent brains more than they did, to seek hard-to-find tumors. But they noted that science is an iterative process; the study wasn’t perfect, but it’s better than anything that’s been done so far.

Overall, the peer reviewers commended the study for its rigorous design and execution. George Corcoran, the chair of the department of pharmaceutical sciences at Wayne State University who sat on the panel, says the study was of a “gold standard for design and conduct” and was “comprehensive and robust throughout.”
WHAT THE STUDIES ACTUALLY FOUND
The papers found that, in male rats, there was “clear evidence” that exposure to cell phone radiation increased risk for a rare type of malignant tumor called schwannoma in the connective tissues that surround nerves in the heart (they found “equivocal” evidence for the same thing in female rats). They also found “some evidence” that the radiation caused malignant glioma—a type of brain cancer affecting glial cells—in the male rats.
There was also “equivocal” evidence that it raised the risk of heart conditions, and led to evidence of DNA damage. Baby rats born to mothers during the trial had lower birth weights. The scientists also found a statistically significant increase in lymphoma (cancer of the lymph nodes) among female mice and heightened rates of liver cancer in the male mice. All those findings were labeled “equivocal.”
As we’ve noted before, animal studies can’t perfectly replicate human cell phone use; you can’t make a rat hold a tiny mobile phone, or put it in its pocket, for example.
But the results of these two rat studies align with those of the biggest cell phone-radiation human study to date, INTERPHONE. The INTERPHONE study, published in 2011, was a coordinated effort by researchers at 16 institutions across 13 countries, and found that the heaviest mobile phone users were more likely to develop glioma—the same type of brain cancer the NTP study found in the male rats. “So there’s a concordance between the animal and human data,” Melnick says.
In response to the INTERPHONE report, the International Agency for Research on Cancer, the cancer arm of the World Health Organization, classified radiation from cell phones as “possibly carcinogenic to humans” in 2011. (Melnick also sat on the panel that made that determination.)
The INTERPHONE authors reported various problems with their data. The study was based in part on interviews with people who already had brain cancer, so could be subject to recall bias, creating plenty of uncertainty.
But Melnick says that when the INTERPHONE study looked at the rates of different types of brain cancer (meningioma, for example) they found no difference cell phone users. He points out that if there was recall bias, “why was it this type and not this other type of cancer?”
The FDA will make the next move in determining the risk posed to humans, and how to interpret the results for the public. “We’re taking a responsible approach,” FDA’s director of the office of science and engineering, Edward Margerrison, said on Wednesday, according to the News & Observer. “We’re not gonna knee-jerk on anything.”
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Diabetes and the plant based diet approach
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”no” min_height=”” hover_type=”none” link=””][fusion_text]
WFPB diets make the news again, positively
By Dr. Alan Kadish NMD
If you read my bio or have been my patient you might know that I’ve been an advocate for a whole food plant based diet (WFPB), forever. No I’m not suggesting that everyone should be a vegan, however it seems more than clear that the best diets are whole food plant heavy and avoid a whole lot of junk (defined as processed, animal based, oils and adulterated foods) for ones best health options.
The research has now become a tsunami of studies related to various risks including heart disease and of course diabetes. In this new study published in the Journal of Nutrients, 75 patients who were already overweight were divided into two groups for 16 weeks. One group did the WFPB diet, with low fat and “with no limit on energy intake” the other group ate their previous “regular” diet. Read the portion size was not restricted for those on the WFPB diet.
The results are telling, “The dietary intervention elicited marked increases in meal-stimulated insulin secretion and beta-cell glucose sensitivity, along with decreased fasting insulin resistance and decreased fasting and postprandial plasma glucose concentrations, in individuals with no history of diabetes.” So in plain english; the pancreas was more effective , the cells took up the sugar (glucose) easier and after a meal the sugar levels were less, which is what you want. Sounds like a trifecta as the body was truly working better, from multiple vantage points.
And not to belabor the point lets also consider the video by Dr. Greger at NutritionFacts.org. Now many of you will be upset to hear that some in the medical community believe that our diet coupled, with environmental insults and genetics may be the primary cause of diabetes. No the science is not 100%, however there certainly is substantial information to suggest that indeed it may be a large part of the underlying cause for a huge percentage of people.
This would of course suggest that the mega billion dollar industry, build around diabetes, is misdirecting the resources which currently focus on drugs vs. diet. And for those who like some figures to really get a sense of the enormity of this issue, the Center for Disease Control (CDC) National Diabetes Statics Report for 2017 states: 30.3 million people are diabetic (9.4%) of the population. And how about a dollar figure ? The Diabetes organization calculates the current cost of this disease at $322 Billion.
For those of you wanting to dive deeper into the subject you might find the following list of Youtube videos of interest:
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
BPA toxicity being played down, swept under the rug by the EPA
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” border_style=”solid” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
BPA’s and endocrine disruptors continue to pose a threat
There never seems to be a lack of controversy when it comes to common chemicals and our health. Once again the FDA is taking a less than truly genuine assessment of the published literature. BPA research continues with new journal articles documenting endocrine disruption in many models. Some examples of recent publications: Effects of Exposure to the Endocrine-Disrupting Chemical Bisphenol A During Critical Windows of Murine Pituitary Development (2017), or Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies Bisphenol A substitutes and obesity in US adults: analysis of a population-based, cross-sectional study
In the latest brouhaha the FDA is using a read the headline approach and downplaying the significance of these chemicals and not waiting for a full report. More upsetting is their endpoints of how to determine the impact of the chemicals. It’s like moving the goal post to get your own result….sans science.
If you don’t think you have BPA’s in your system, think again. As reported in the BMJ Open Diabetes Research & Care in February they examined 96 adolescents, 86% had measurable levels of BPA in their urine and it did not go down after trying to avoid BPA for 7 days. Been drinking from the 5 gal water bottle at the office or did you handle receipts from the local shopping store or recently took a trip and handled airline tickets ? All of these are full of BPA’s or other of this chemical family.
If you have doubts about what other think from a scientific point of view, it will be of interest to know that the European chemicals agency (Echa) voted unanimously that bisphenol A (BPA) was an ‘endocrine disruptor’, linking it to a range of hormone-twisting health effects including cancer, learning difficulties and diabetes.
The real question is do we need to choose between safe and really safe ? This will inevitably be an ongoing story as the original BPA now has two often substituted chemical cousins, BPF and BPS…. and no there are no labeling requirements and these too cause the same or more disruption of our endocrine system.
What can you do ?
Stay away from polycarbonate plastic products (think 5 gallon water bottles and look for the letters “PC” by the recycling label #7)
Purchase tomato sauce in glass rather than plastic or canned
Don’t take receipts from the store and if you do, don’t put them in your pockets !
Suggestion take a picture of the receipt for your records or use an app
Don’t buy canned foods or beverages that don’t say BPA free (its a start)
Airline tickets are another no-no, use your phone’s app
Copyright Center of Health™ 3/2018 For permission to reprint this article, please contact the author.
FDA, endocrinologists at odds over agency’s latest BPA safety claims


The HHS National Toxicology Program issued a draft report in February suggesting that rodents exposed to the endocrine-disrupting chemical bisphenol A experienced only “minimal effects,” leading the FDA to reaffirm its stance that the chemical is “safe for consumers” at current levels in food packaging.
But the FDA’s safety claim, issued in a press release Feb. 23, has alarmed hormone science experts and some toxicologists, who claim the interim data — based on an incomplete report that has not undergone peer review — are premature. In a statement rebutting the FDA’s claim, the Endocrine Society noted that the study did not examine areas of key concern, such as the effect of bisphenol A (BPA) on brain development. The interim report, conducted at the FDA’s National Center for Toxicological Research (NCTR), instead focused on how BPA exposure affected growth, weight and tumor development in animal models, and experts caution that those data, too, are concerning.
“Bisphenol A has a molecular structure that can interact with several different receptors at the same time,” R. Thomas Zoeller, PhD, a member of the Endocrine Society’s EDC Advisory Group committee and professor of biology at the University of Massachusetts, told Endocrine Today. “This is something that is unheard in the natural hormone system. BPA can interact with the estrogen receptor, but also the androgen receptor and the thyroid hormone receptor. It produces this combination effect, and it’s very difficult to track it down [in research] because of that. We don’t have any pharmaceuticals that do such a thing, and, in fact, you wouldn’t want to have any pharmaceuticals that do such a thing.”
Adding more complexity to the BPA debate is the way the chemical can cause hormone receptors to behave within the context of “normal receptor actions,” Zoeller said.
“What that means is BPA can interact with the estrogen receptor and cause it to do what it normally does, but maybe it’s not the right time or place,” Zoeller said. “This is also very difficult to track down. All these industrial chemicals that react with receptors have that feature. None of them produce a perfect hormonal profile. They cause dysregulation.”
Questioning safety
The interim NCTR report is part of a larger, collaborative effort by the FDA and the National Institute of Environmental Health Sciences called CLARITY-BPA, a consortium established after a 2008 National Toxicology Program report raised concerns about developmental effects in rodents exposed to low doses of BPA. In the NCTR core study, researchers evaluated chronic and early life exposure to five doses of BPA in two groups of rodents, ranging from low (typical human exposure) to high. Overall, the study suggested there were “minimal effects” for rodents exposed to BPA, according to the FDA; however, the report identified an increase in mammary gland tumors at one of the five doses, in one of the rodent groups.
“The significance of these findings will be assessed through the peer-review process,” Stephen Ostroff, MD, deputy commissioner for foods and veterinary medicine at the FDA, said in a press release.
The second component of CLARITY-BPA includes academic studies of BPA’s effects on additional relevant endpoints, conducted by grantees at academic institutions and using offspring of rodents derived from the core NCTR study. An integrated report incorporating the core study with data from grantees will be published later, according to the FDA.
Zoeller said the endpoints studied in the NCTR report do not provide assurance that BPA is safe. The Endocrine Society is also calling on policymakers and regulators to “reserve judgement” until the full CLARITY report is released.
From the point of view of endocrinology, I’m not sure what rat uterine weight means for the human population, but the FDA seems to be OK with that,” Zoeller said. “The FDA is looking at traditional endpoints that are 50 to 70 years old. We know more now about how hormones work and what they do, and there are better endpoints to use. But, those endpoints can be sophisticated, and it doesn’t lend itself readily to a rapid, cheap analysis.”
A common exposure
In 2012, the FDA granted two petitions requesting that the agency amend its food additive regulations to no longer provide for the use of certain BPA-based materials in baby bottles, sippy cups and infant formula packaging because these uses have been abandoned. But the chemical, experts caution, remains almost impossible to avoid. The FDA allows BPA use in polycarbonate plastics and epoxy resins in certain food and beverage can linings (noting it is safe for such authorized uses), and the chemical is also found in other common products, such as thermal cash register receipts.
In a citizen science-based study published in BMJ Open Diabetes Research & Carein February, Lorna Harries, PhD, associate professor in molecular genetics at the College of Life and Environmental Sciences at the University of Exeter, United Kingdom, and colleagues analyzed data from 94 adolescents who partnered with researchers to create real-world diets attempting to avoid BPA exposure for 7 days. The students designed all materials, including study protocols, food diaries, lifestyle questionnaires and patient-information sheets, and were asked to record daily diet details, including food and drink, and any associated packaging for 7 days. Students were asked not to alter diets before the intervention began.
Within the cohort, 86% of participants had at least trace amounts of urinary BPA at baseline. After 7 days, the teens experienced no change in urinary BPA levels and reported difficulty in avoiding the endocrine-disrupting chemical.
“Based on our evidence, it is extremely difficult to reduce one’s own exposure to BPA by actively trying to avoid known sources,” Harries told Endocrine Today. “Our study indicates that the control over exposure to BPA currently does not lie with the consumer. At present, the ubiquitous nature of BPA in our environment and inadequacies in current labeling practices mean that it is very difficult to identify BPA-free foods.”
Maricel Maffini, PhD, an independent consultant with the nonprofit Environmental Defense Fund, said it is difficult to pinpoint specific foods or plastic products that could potentially contain problematic levels of BPA.
“Even if a product’s final package is not polycarbonate or a metal can that is coated with a BPA-base epoxy resin, there is no guarantee that BPA is not in the food because of the supply chain,” Maffini told Endocrine Today. “We don’t know how the individual ingredients were prepared, or if polycarbonate was used at any point in the manufacturing process, or if there were other kinds of metal cans coated with BPA used that are not in the final packaging we see in the supermarket. It is an ongoing issue, and I don’t think labeling is going to be the solution.”
Making changes
Consumers looking to avoid BPA exposure will find it difficult, Maffini said: Even plastic products with a “BPA-free” label could contain another endocrine-disrupting chemical as a replacement, such as bisphenol S or bisphenol F.
“The ideal situation for those concerned about being exposed to BPA is to increase the consumption of frozen, rather than canned, vegetables,” Maffini said. “Buy tomato sauce in a glass jar rather than plastic or canned.”
Additionally, people more sensitive to estrogen exposure, such men and women trying to conceive or women with certain types of breast cancer, may want to take care to avoid polycarbonate plastic as much as possible, Maffini said. That can be difficult, she added, depending on a person’s access to alternative products.
“It is not our responsibility to choose between safe and less safe,” Maffini said. “Everything must be safe when it comes to food additives. People can call the companies and ask, and if they are changing brands because one is advertising BPA-free food, they should ask, ‘What did you use to replace it?’ That’s the other problem. We have very little information on what is being used to replace BPA.”
Zoeller said evidence suggests that changes in behavior will most likely not change a person’s BPA-exposure level, but consumers should avoid plastics as much as possible and should not put plastic items in the microwave or dishwasher.
“You do what you can to mitigate the risk, even if the risk is small, knowing also that there are those entities working hard to maintain the status quo,” Zoeller said.
“It’s clear that plastics can be produced without estrogenic activities,” Zoeller said. “That’s been demonstrated. The only thing keeping us from doing it is political will. It is feasible to eradicate estrogenic chemicals from our food and products, but the social perception or awareness of the risk is an issue that we must deal with, and we have to deal with the relationship between industry and government.” – by Regina Schaffer
References:
HHS. CLARITY-BPA program. Available at: https://ntp.niehs.nih.gov/results/areas/bpa/clarity_bpa/clarity-bpa-program.html.
FDA. Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm598100.htm.
For more information:
Maricel Maffini, PhD, can be reached at drmvma@gmail.com.
R. Thomas Zoeller, PhD, can be reached at tzoeller@bio.umass.edu.
Disclosures: Maffini and Zoeller report no relevant financial disclosures.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Is it Alzheimer’s, Depression or both , scan the brain
[fusion_builder_container type=”flex” hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
Alzheimer’s and Depression have significant overlap
By Dr. Alan Kadish
In a study looking at blood flow in the brain of 4500+ patients, researchers were able to distinguish the difference between those with depression, depression and cognitive dysfunction or both with between ~83%-86% accuracy. They used a SPECT scanner to obtain a high tech 3-D image of the patient’s blood flow in the brain.
A SPECT scanner is a high tech imaging device that in some ways resembles an MRI in appearance, however with different technology. A gamma-emitting radioisotope (a radionuclide) substance is given via an IV and a camera looks at the the brain from 360 degrees.
With the increasing number of patients displaying the appearance of being demented and having depression or a combination it’s critical to determine the underlying disorder. With the overlap in symptoms this technology is a welcome addition to our evaluations.
In using this technology we can now distinguish between the two or the combined more effectively. The use of SPECT imaging is not common place and tends to be expensive, typically in the $~2000 range. The treatments are very different and can be personalized appropriately.
At the Center of Health we use cognitive evaluation software, used on a computer and game like to do our initial evaluations. It can give great insight into your brain function and direct us to the appropriate next steps.
Call us at the Center and arrange for a brain evaluation. Better function for a better life. 541.773.3191
Is it Depression or Dementia? Brain SPECT Imaging Helps Distinguish Them
15 February 2017

Neuroimaging of decreased blood flow in specific regions of the brain can differentiate between depression and cognitive disorders, according to a new report in the Journal of Alzheimer’s Disease.
Amsterdam, NL, February 15, 2017 – Does a patient have depression or a cognitive disorder (CD) such as Alzheimer’s disease or both? Since both disorders have overlapping symptoms, how can a clinician tell them apart to make the appropriate diagnosis? In a new article published in the Journal of Alzheimer’s Disease, researchers have found that single photon emission computed tomography or SPECT, can help to distinguish between these diagnostic categories.
Comparison of Both Dementia and Depression Patients
In one of the largest studies of its kind, 4541 subjects were examined, 847 of whom were diagnosed with dementia, 3269 with depression, and 425 with both conditions. Using brain SPECT imaging, a nuclear medicine study that measures blood flow and activity, researchers found that people with cognitive disorders had reduced blood flow in multiple brain areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes.
They also found that SPECT could distinguish depression from CDs with 86% accuracy. Also, brain SPECT imaging showed the ability to identify depression or dementia in people with both with 83% accuracy.
“This is a critical clinical question that has practical implications for patient management and treatment,” explained lead researcher and psychiatrist Daniel G. Amen, MD. “These disorders have very different prognoses and treatments and being able to improve diagnostic accuracy can improve outcomes for some patients.”
The Breakdown
The authors write, “Cognitive impairment is present in approximately half of persons who have late onset depression and depression is evident in 9-65% of individuals with dementia. Studies have indicated that the prevalence of depression in patients with mild cognitive impairment is 25%. Consequently, it is often challenging to diagnostically disentangle depression and cognitive disorders from one another.”
Traditionally, depression can be diagnosed using tools such as the Beck Depression Inventory, the most widely used psychometric test for measuring the level of depression. However, there was no statistically significant difference in the burden of depression symptoms on this inventory between individuals with both depression and CDs compared to persons with either condition. This increases the difficulty of distinguishing these disorders on the basis of depression symptom severity alone.
“One of the greatest new insights of the past decade is the linkage of depression to the psychology of late-life cognitive decline. Raji and coworkers extend the approach to the biological substrate by an elegant imaging approach. These studies further place brain aging on a firm biological basis,” added George Perry, PhD, Editor-in-Chief of the Journal of Alzheimer’s Disease and Dean and Professor of Biology University of Texas at San Antonio.
If you or a loved one is experiencing symptoms of Alzheimer’s disease, dementia or depression, Amen Clinics can help. We will help you learn more about your brain and assist with early diagnosis and intervention. Call us today at (855) 899-7807 or visit our website to schedule a visit.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
Get time with your Doctor an oxymoron ?….See what John Hopkins says
[fusion_builder_container type=”flex” hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text]
Why should you need to beg for time with your physician ?
by Dr. Alan Kadish NMD
The newest evaluation at three John Hopkins outpatient clinics tells an interesting story. Most patients will tell you that they want quality and some quantity of time, with their health care provider. Generally, this equates to the typical 8-12 minutes of “face” time with the practitioner who is filling in the electronic records, as you speak, to save time. It turns out that after looking at 23,635 patient-doctor interactions they found that the perception of being on time or behind will ultimately influence the contact time you get with the doctor.
Not surprisingly they found that the physician’s sense of urgency was based on their feeling the pace of the day and not the actual situation from a time perspective. The ultimate result of the study….. “If a doctor is more consistent in the amount of time spent with each patient, wait times tend to go down, and it puts less pressure on the doctor to make up the time by rushing,” . If this sounds a bit computer’ish it is. They did computer simulations to determine the best method to keep time in check and maximize efficiency. Are you feeling like an object again, so much for personalized medicine ? How about their reference to “processing times” ?
With the Center’s approach using concierge medicine, it’s not about maximizing efficiency for time and profit. We schedule the necessary time to listen and work as a team. Not to place you in an exam room and keep a smooth flow of patient’s. One of the most disturbing aspects of this report is the move to keep patients “on time”……without recognizing that all patients are DIFFERENT and need varying levels of services.
I’ll never forget one of my rotations with a well-respected physician. His method was to limit the patient to one complaint per visit and keep the time of contact consistent to maximize the clinic’s efficiency and income
The facial expressions on the patients, especially those with multiple issues that were obviously pressing and being detoured to another appointment, was not only sad to watch but also limited the ability for any clinician to get the whole story. Yes, the doc was perceived as a good doctor, as he had a great way of deflecting their concerns, but clearly missed lots of cues and was not practicing quality medicine, from my perspective.
So ask yourself next visit to your clinic and physician….. were all of your questions answered ? Did you see their face or were they glued to a computer screen ?
Human interaction and not a computer is the key. It’s the art….. and science of medicine which demands, taking the time to examine and ask questions that results in the ability to derive a great plan of action.
Ready for a quality interaction with a physician who is both current with medical information and options ? Do you want to leave the interaction feeling you got what you needed and feel satisfied ? Call us at the Center of Health 541.773.3191
Source: Johns Hopkins Medicine
What Can You Do To Have More ‘Face Time’ With Your Doctor? Arrive Early For The Appointment
A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.
The researchers say the retrospective study, summarized in a report published in BMJ Open, confirms for health care services what is a commonly observed phenomenon in grocery store and bank teller lines: Once lines get backed up, service providers become less consistent in their behaviors and “shortchange” time spent with customers in order to catch up.
“We definitely demonstrated that the amount of time physicians spend with patients is influenced by whether doctors perceive their clinics are running on or behind schedule,” according to the study’s clinical leader Kayode Williams, MD, MBA, associate professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine. “There is always tension between spending time with patients so they leave feeling I’ve really listened to them and keeping patients’ wait times down. I believe there is a happy medium that can be met that depends heavily on a consistent flow in the clinic. Waiting is one of the most common complaints about outpatient clinics, so understanding behavior is key to finding ways to see a growing number of patients efficiently while still offering high-value care,” he says.
Williams says the new research was inspired by the results of previous studies, which showed that enforcing patient punctuality reduced variability in patient wait time. The new investigation, he says, was specifically designed to learn whether physicians’ behaviors also affected clinic efficiency.
For this study, the Johns Hopkins team gathered data on patient appointment time, patient arrival time, patient interactions in the clinic and physician-patient interaction from a low-volume pain management clinic, a medium-volume academic pain management clinic and a high-volume radiation oncology service. In all, 23,635 patient-doctor interactions were examined.
The patients at each clinic were sorted into three groups: Group A was composed of those who arrived at the clinic and were present in the examination room before their scheduled appointment time; group B was composed of those who arrived before their appointment time but were not in the examination room until after their appointment time, indicating that the clinic was congested; and group C was composed of those who arrived at the clinic after their appointment time. While many physicians believe that all patients receive the same level of service, analysis of the data revealed that the average time that physicians spent with each group varied.
For the low-volume clinic, the average processing time for groups A, B and C were 38.31, 26.23 and 29.50 minutes, respectively. For the medium-volume clinic, these values were 65.59, 53.53 and 50.91 minutes, respectively. And for the high-volume clinic, the study reported 47.51, 17.59 and 47.90 minutes for groups A, B and C, respectively. While intuition may suggest that adapting behavior to catch up with the clinic’s schedule will help the clinic run smoother, the researchers found that it harms the efficiency of a clinic by adding unpredictable time variability to the system.
To explore the implications of the findings, the researchers plugged their data into a computer model known as discrete event simulation, which artificially expands the sample size to thousands more theoretical patients.
Calculating the impact of their data sample on a computer model of 10,000 doctor-patient sessions, the researchers found that even if patient tardiness is eliminated, physician behavior would cause the clinic to run behind schedule.
This led the researchers to conclude that while patient punctuality is a real factor in lengthening wait times, physician behavior may have a larger impact on the clinic’s efficiency.
“We didn’t originally think that physicians would be aware of the congestion in the clinic because they were not out in the waiting room seeing the congestion,” says Maqbool Dada, PhD, professor of operations management and business analytics at Johns Hopkins Carey Business School with a joint appointment in anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine. “But it appears they could sense the rhythm of the clinic.”
To further test their conclusions, the researchers again turned to their computer model to create a “clinic” in which all patients were treated as though they were in group B, receiving the average amount of face-to-face time with physicians. In this model, the researchers saw that both the average time it took to get patients from check-in to checkout and the variability in those times among patients could be reduced by changing clinician behavior to be more consistent across all patients.
Considering the same clinic with more consistent behavior, waiting times would drop by 34 percent.
“The take-home message is that one way to ease the trade-off between wait time and face time is to reduce uncertainty in the overall system,” says Chester Chambers, PhD, assistant professor of operations management at Johns Hopkins University Carey Business School and an associate faculty member at the Johns Hopkins Armstrong Institute for Patient Safety and Quality.
“If a doctor is more consistent in the amount of time spent with each patient, wait times tend to go down, and it puts less pressure on the doctor to make up the time by rushing,” Chambers adds.
Chambers says the research team is developing protocols to expand similar time management research in more clinics.
Because of the US’s aging population, he says, demand for health services will continue to rise. “We need to make things go smoother so that we can see more patients without sacrificing quality.”
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]










